Easterly Investment Partners’s Quest Diagnostics DGX Stock Holding History

Easterly Investment Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,379	Closed	-$1.86M	–	205
2025 Q2	$1.86M	Buy	+10,379	New	+$1.8M	0.13%	119
2020 Q4	–	Sell	-118,942	Closed	-$13.6M	–	137
2020 Q3	$13.6M	Sell	118,942 -5,314	-4%	-$628K	0.54%	34
2020 Q2	$14.2M	Sell	124,256 -299,323	-71%	-$31.7M	0.64%	35
2020 Q1	$34M	Buy	423,579 +409,692	+2,950%	+$42.4M	1.51%	30
2019 Q4	$1.48M	Sell	13,887 -195,290	-93%	-$20.4M	0.04%	50
2019 Q3	$22.4M	Sell	209,177 -113,581	-35%	-$11.7M	0.63%	34
2019 Q2	$32.9M	Sell	322,758 -1,084,523	-77%	-$104M	0.82%	35
2019 Q1	$127M	Buy	+1,407,281	New	+$122M	3.05%	13

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Easterly Investment Partners's DGX Position: Q3 2025 in Review

Easterly Investment Partners sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 10,379 shares — an estimated $1.86M sold.

Easterly Investment Partners first reported a position in DGX in Q1 2019 and held it in 8 quarters. The position peaked at $127M in Q1 2019. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

Easterly Investment Partners reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
Easterly Investment Partners sold 10,379 Quest Diagnostics shares in Q3 2025, an estimated $1.86M.
Easterly Investment Partners first reported a position in Quest Diagnostics in Q1 2019 and held it in 8 quarters.
Easterly Investment Partners's Quest Diagnostics position peaked at $127M in Q1 2019.
1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Easterly Investment Partners's 13F filing for Q3 2025, filed 12 Nov 2025.